Dynamics of humoral and T-cell immunity after three BNT162b2 vaccinations in adults older than 80 years - The Lancet

A third mRNA-based booster vaccination is the currently favoured strategy to maintain protection against SARS-CoV-2 infection. Yet, significant waning of specific immunity within 6 months after two doses,1 along with a higher incidence of breakthrough infecti…

We use cookies to help provide and enhance our service and tailor content and ads. To update your cookie settings, please visit the Cookie Preference Center for this site.Copyright © 2022 Elsevier In… [+173 chars]

full article...